Discounted Cash Flow
Merit Medical Systems Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $603.8m | $20.1m | $20.8m | 3.3% | $0.45 |
| 2017 | $727.9m (20.5%) | $27.5m (36.8%) | $24.1m (16.1%) | 3.8% (13.5%) | $0.56 (24.4%) |
| 2018 | $882.8m (21.3%) | $42.0m (52.7%) | $23.2m (-3.7%) | 4.8% (25.9%) | $0.80 (42.9%) |
| 2019 | $994.9m (12.7%) | $5.5m (-87.0%) | $-360.0k (-101.6%) | 0.5% (-88.5%) | $0.10 (-87.5%) |
| 2020 | $963.9m (-3.1%) | $-9.8m (-280.6%) | $-9.8m (-2634.2%) | -1.0% (-286.4%) | $-0.18 (-280.0%) |
| 2021 | $1.1b (11.5%) | $48.5m (592.3%) | $119.3m (1311.9%) | 4.5% (541.5%) | $0.86 (577.8%) |
| 2022 | $1.2b (7.1%) | $74.5m (53.8%) | $69.3m (-41.9%) | 6.5% (43.6%) | $1.31 (52.3%) |
| 2023 | $1.3b (9.2%) | $94.4m (26.7%) | $110.9m (60.1%) | 7.5% (16.0%) | $1.64 (25.2%) |
| 2024 | $1.4b (7.9%) | $120.4m (27.5%) | $185.7m (67.5%) | 8.9% (18.2%) | $2.07 (26.2%) |
| 2025 | $1.5b (11.8%) | $128.5m (6.8%) | $215.7m (16.2%) | 8.5% (-4.5%) | $2.17 (4.8%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.